AP NEWS

Baxter Unveils New Products at the ASMBS – Obesity Week Meeting to Help Surgeons Overcome Challenges During Bariatric Surgery

November 14, 2018

NASHVILLE, Tenn.--(BUSINESS WIRE)--Nov 14, 2018--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, revealed its Peri-Strips Dry with Veritas (PSDV) Circular Staple Line Reinforcement with Secure Grip technology, the latest evolution in a product portfolio that has more than 20 years of proven clinical use in surgical buttressing and soft tissue repair. PSDV Circular is being showcased alongside the company’s comprehensive Advanced Surgery portfolio at the 2018 American Society for Metabolic and Bariatric Society (ASMBS) – Obesity Week meeting this week.

“Our latest advancements with Peri-Strips Dry with Veritas demonstrate how we are using customer-inspired innovation from our trusted products to promote better healing, particularly as the number of bariatric procedures being performed is rising,” said Wil Boren, president of Baxter’s Advanced Surgery business.

PSDV Circular, with the included cartridge cone, is designed to allow a circular surgical stapler to advance across the incision site with minimal tissue injury while protecting the buttress. PSDV Circular also features Baxter’s Secure Grip technology, which provides secure placement of PSDV onto a circular surgical stapler. PSDV Circular is easy-to-load through a peel-and-stick configuration and can be used in a range of surgical procedures.

During bariatric procedures, surgeons use a variety of techniques to reduce the risk of significant complications such as staple line leaks and bleeds. To reduce this risk, many surgeons choose to buttress, or reinforce, the staple line with biologic buttressing patches like Baxter’s PSDV Circular product.

“I have been using Peri-Strips Dry with Veritas for many years to reinforce the staple line in my patients, and I’m excited to have this new version that will work with circular staplers now. It’s going to make it easier for me to buttress at the staple line, which I believe is important for my patients to improve outcomes after their operations,” said Eric S. Hungness, M.D., a general and bariatric surgeon at Northwestern Medical Group in Chicago, Ill.

Baxter is also showcasing during ASMBS - Obesity Week the company’s new next-generation syringe that makes it easier to control the application of the fibrin sealant along the staple line. Additionally, the company is launching a new longer rigid applicator for Tisseel that will be especially helpful during laparoscopic procedures, including bariatric procedures, where a surgeon requires greater length to apply Tisseel to bleeding sites that are difficult to reach.

Attendees can visit booth #918 to see demonstrations of these new products, as well as the rest of Baxter’s portfolio that can help surgeons during bariatric procedures.

About Baxter’s Surgery Portfolio

Baxter is committed to partnering with clinicians to make a meaningful impact on patient care in operating rooms (OR) in nearly 60 countries. Surgeons rely on our hemostats to stop bleeding during surgery, our sealants to close wounds, and our repair patches and biologics to promote healing. We are focused on pioneering innovative and dependable surgical tools and programs that help to improve clinical outcomes while reducing the total cost of care.

About Baxter

Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit  www.baxter.com  and follow us on  TwitterLinkedIn  and  Facebook.

Tisseel [Fibrin Sealant] Indications

Hemostasis: Tisseel is a fibrin sealant indicated for use as an adjunct to hemostasis in adult and pediatric patients (>1 month of age) undergoing surgery when control of bleeding by conventional surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical. Tisseel is effective in heparinized patients.

Sealing: Tisseel is a fibrin sealant indicated as an adjunct to standard surgical techniques (such as suture and ligature) to prevent leakage from colonic anastomoses following the reversal of temporary colostomies.

Selected Important Risk Information for Tisseel

For Topical Use Only. Do not inject Tisseel directly into the circulatory system or into highly vascularized tissue. Intravascular application of Tisseel can lead to intravascular coagulation, can result in life-threatening thromboembolic events, and can increase the likelihood and severity of acute hypersensitivity reactions in susceptible patients. Do not use Tisseel in individuals with a known hypersensitivity to aprotinin. Apply Tisseel as a thin layer by dripping or spraying using cannula or spray set. Do not use Tisseel for the treatment of severe or brisk arterial or venous bleeding. Hypersensitivity or allergic/anaphylactoid reactions can occur with the use of Tisseel.

Peri-Strips Dry with Veritas Collagen Matrix (PSDV) Staple Line Reinforcement - Important Risk Information

INDICATIONS FOR USE

PSDV Reinforcement is intended for use as a prosthesis for the surgical repair of soft tissue deficiencies using surgical staplers when staple line reinforcement is needed.

(Circular reinforcement only) PSDV can be used for reinforcement of staple lines during gastric, bariatric, and small bowel procedures.

(Linear reinforcement only) PSDV can be used for reinforcement of staple lines during lung and bronchus resections and during bariatric surgical procedures. PSDV can be used for reinforcement of staple lines during gastric, small bowel, mesentery, colon, and colorectal procedures.

IMPORTANT RISK INFORMATION

The use of PSDV is contraindicated in patients with known sensitivity to bovine or acrylic material.

Final tissue compression, including PSDV, must meet the range specified by the stapler manufacturer; this is especially important if staple firings are overlapped.

Rx Only. For safe and proper use of this device, refer to the complete Instructions for Use.

This release includes forward-looking statements concerning Peri-Strips Dry with Veritas and Tisseel, including potential benefits associated with their use and information about planned commercial launches. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; product quality, manufacturing or supply, or patient safety issues; changes in law and regulations; and other risks identified in Baxter’s most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter’s website. Baxter does not undertake to update its forward-looking statements.

Baxter, Peri-Strips Dry, Veritas, Tisseel and Secure Grip are registered trademarks of Baxter International Inc.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181114005466/en/

CONTACT: Baxter International Inc.

Media Contact

Beth Mueller, (224) 948-5353

media@baxter.com

or

Investor Contact

Clare Trachtman, (224) 948-3085

KEYWORD: UNITED STATES NORTH AMERICA ILLINOIS TENNESSEE

INDUSTRY KEYWORD: SURGERY HEALTH MEDICAL DEVICES PHARMACEUTICAL MEDICAL SUPPLIES GENERAL HEALTH

SOURCE: Baxter International Inc.

Copyright Business Wire 2018.

PUB: 11/14/2018 08:15 AM/DISC: 11/14/2018 08:15 AM

http://www.businesswire.com/news/home/20181114005466/en

AP RADIO
Update hourly